Balyasny Asset Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Sell |
198,859
-55,487
| -22% | -$37.7K | ﹤0.01% | 1864 |
|
|
2025
Q1 | $184K | Sell |
254,346
-88,884
| -26% | -$64.4K | ﹤0.01% | 1831 |
|
|
2024
Q4 | $328K | Buy |
343,230
+70,744
| +26% | +$67.6K | ﹤0.01% | 1601 |
|
|
2024
Q3 | $215K | Hold |
272,486
| – | – | ﹤0.01% | 1773 |
|
|
2024
Q2 | $258K | Sell |
272,486
-66,056
| -20% | -$62.6K | ﹤0.01% | 1645 |
|
|
2024
Q1 | $366K | Buy |
+338,542
| New | +$366K | ﹤0.01% | 1590 |
|